Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2008

Open Access 01-12-2008 | Research article

Comparing estimates of influenza-associated hospitalization and death among adults with congestive heart failure based on how influenza season is defined

Authors: Carolyn Sandoval, Stephen D Walter, Paul Krueger, Mark B Loeb

Published in: BMC Public Health | Issue 1/2008

Login to get access

Abstract

Background

There is little consensus about how the influenza season should be defined in studies that assess influenza-attributable risk. The objective of this study was to compare estimates of influenza-associated risk in a defined clinical population using four different methods of defining the influenza season.

Methods

Using the Studies of Left Ventricular Dysfunction (SOLVD) clinical database and national influenza surveillance data from 1986–87 to 1990–91, four definitions were used to assess influenza-associated risk: (a) three-week moving average of positive influenza isolates is at least 5%, (b) three-week moving average of positive influenza isolates is at least 10%, (c) first and last positive influenza isolate are identified, and (d) 5% of total number of positive isolates for the season are obtained. The clinical data were from adults aged 21 to 80 with physician-diagnosed congestive heart failure. All-cause hospitalization and all-cause mortality during the influenza seasons and non-influenza seasons were compared using four definitions of the influenza season. Incidence analyses and Cox regression were used to assess the effect of exposure to influenza season on all-cause hospitalization and death using all four definitions.

Results

There was a higher risk of hospitalization associated with the influenza season, regardless of how the start and stop of the influenza season was defined. The adjusted risk of hospitalization was 8 to 10 percent higher during the influenza season compared to the non-influenza season when the different definitions were used. However, exposure to influenza was not consistently associated with higher risk of death when all definitions were used. When the 5% moving average and first/last positive isolate definitions were used, exposure to influenza was associated with a higher risk of death compared to non-exposure in this clinical population (adjusted hazard ratios [HR], 1.16; 95% confidence interval [CI], 1.04 to 1.29 and adjusted HR, 1.19; 95% CI, 1.06 to 1.33, respectively).

Conclusion

Estimates of influenza-attributable risk may vary depending on how influenza season is defined and the outcome being assessed.
Literature
1.
Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB: Impact of Respiratory Virus Infections on Persons with Chronic Underlying Conditions. JAMA. 2002, 283: 499-505. 10.1001/jama.283.4.499.CrossRef
2.
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States. JAMA. 2003, 289: 179-186. 10.1001/jama.289.2.179.CrossRefPubMed
3.
Simonsen L, Fukuda K, Schonberger LB, Cox NJ: The Impact of Influenza Epidemics on Hospitalizations. J Infect Dis. 2000, 181: 831-837. 10.1086/315320.CrossRefPubMed
4.
Barker WH: Excess Pneumonia and Influenza Associated Hospitalization during Influenza Epidemics in the United States, 1970–1978. Am J Public Health. 1986, 76: 761-765.CrossRefPubMedPubMedCentral
5.
Centers for Disease Control and Prevention: Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (No. RR-3). 2000, 49-
6.
Lin JC, Nichol KL: Excess Mortality Due to Pneumonia or Influenza During Influenza Seasons Among Persons With Acquired Immunodeficiency Syndrome. Arch Intern Med. 2001, 161: 441-446. 10.1001/archinte.161.3.441.CrossRefPubMed
7.
Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K: Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young Children. N Eng J Med. 2000, 342: 232-239. 10.1056/NEJM200001273420402.CrossRef
8.
Maletic Neuzil K, Reed GW, Mitchel EF, Griffin MR: Influenza-Associated Morbidity and Mortality in Young and Middle-Aged Women. JAMA. 1999, 281: 901-907. 10.1001/jama.281.10.901.CrossRef
9.
Maletic Neuzil K, Reed GW, Mitchel EF, Griffin MR: The Burden of Influenza Illness in Children with Asthma and Other Chronic Medical Conditions. J Pediatr. 2000, 137: 856-864. 10.1067/mpd.2000.110445.CrossRef
10.
Nichol KL, Margolis KL, Wuorenma J, von Sternberg T: The Efficacy and Cost-Effectiveness of Vaccination Against Influenza among Elderly Persons Living in the Community. N Engl J Med. 1994, 331: 778-784. 10.1056/NEJM199409223311206.CrossRefPubMed
11.
Hurwitz ES, Haber M, Chang A, Shope T, Teo S, Ginsberg M, Waecker N, Cox NJ: Effectiveness of Influenza Vaccination of Day Care Children in Reducing Influenza-Related Morbidity Among Household Contacts. JAMA. 2000, 284: 1677-1682. 10.1001/jama.284.13.1677.CrossRefPubMed
12.
Buxton-Bridges C, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Kilmov A, Fukuda K: Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults. JAMA. 2000, 284: 1655-1663. 10.1001/jama.284.13.1655.CrossRef
13.
Nichol KL, Baken L, Nelson A: Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease. Ann Intern Med. 1999, 130: 397-403.CrossRefPubMed
14.
Govaert TME, Thijs CTMCN, Masurel N, Sprenger MJW, Dinant GJ, Knottnerus JA: The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-Blind Placebo Controlled Trial. JAMA. 1994, 272: 1661-1665. 10.1001/jama.272.21.1661.CrossRefPubMed
15.
Hak E, Verhheij TJM, van Essen GA, Lafeber AB, Grobbe DE, Hoes AW: Prognostic Factors for Influenza-Associated Hospitalization and Death During an Epidemic. Epidemiol Infect. 2001, 126: 261-268. 10.1017/S0950268801005180.CrossRefPubMedPubMedCentral
16.
Sandoval C, Walter SD, Krueger P, Smieja M, Smith A, Yusuf S, Loeb M: Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure. 1986–1991. Epidemiology and Infection. 2006, 29: 1-9.
17.
The SOLVD Investigators: Studies of Left Ventricular Dysfunction – Rationale, Design, and Methods: Two Trials That Evaluate the Effect of Enalapril in Patients with Reduced Ejection Fraction. Am J Cardiol. 1990, 66: 315-322. 10.1016/0002-9149(90)90842-O.CrossRef
18.
Criteria Committee of the American Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 1994, Boston (Mass): Little, Brown & Co, 253-256. 9
19.
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A New Method of Classifying Prognostic Comorbidity in Longitudinal Studies: Development and Validation. Journal of Chronic Diseases. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed
20.
Centers for Disease Control and Prevention: Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports (No. RR-3). 2000, 51-
21.
Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K: Influenza-associated hospitalizations in the United States. JAMA. 2004, 292: 1333-40. 10.1001/jama.292.11.1333.CrossRefPubMed
22.
Stewart S, McIntyre K, Capewell S, et al: Heart Failure in a Cold Climate. J Am Coll Cardiol. 2002, 39: 760-66. 10.1016/S0735-1097(02)01685-6.CrossRefPubMed
23.
van Rossum CTM, Shipley MJ, Hemingway H, et al: Seasonal Variation in Cause-Specific Mortality: Are There High-Risk Groups? 25-Year Follow-Up of Civil Servants From the First Whitehall Study. International Journal of Epidemiology. 2001, 30: 1109-16. 10.1093/ije/30.5.1109.CrossRefPubMed
24.
Boulay F, Berthier F, Sisteron O, et al: Seasonal Variation in Chronic Heart Failure Hospitalizations and Mortality in France. Circulation. 1999, 100: 280-86.CrossRefPubMed
25.
Curriero FC, Heiner KS, Samet JM, et al: Temperature and Mortality in 11 Cities of the Eastern United States. American Journal of Epidemiology. 2002, 155: 80-7. 10.1093/aje/155.1.80.CrossRefPubMed
26.
Barnett AG, Dobson AJ, McElduff P, Salomaa V, Kuulasmaa K, Sans S: Cold periods and coronary events: an analysis of populations worldwide. Journal of Epidemiology and Community Health. 2005, 59: 551-7. 10.1136/jech.2004.028514.CrossRefPubMedPubMedCentral
Metadata
Title
Comparing estimates of influenza-associated hospitalization and death among adults with congestive heart failure based on how influenza season is defined
Authors
Carolyn Sandoval
Stephen D Walter
Paul Krueger
Mark B Loeb
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2008
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-8-59

Other articles of this Issue 1/2008

BMC Public Health 1/2008 Go to the issue

Research article

Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies

Research article

Health-related quality of life among general practice patients with differing chronic diseases in Germany: Cross sectional survey

Research article

How effective is good domestic kitchen hygiene at reducing diarrhoeal disease in developed countries? A systematic review and reanalysis of the UK IID study

Research article

Psychiatric disorders and urbanization in Germany

Research article

Chronic disease prevalence and associations in a cohort of Australian men: The Florey Adelaide Male Ageing Study (FAMAS)

Research article

Lung cancer mortality in towns near paper, pulp and board industries in Spain: a point source pollution study